Matthew T. David, Chief Financial Officer at CorMedix Inc. (CRMD), bought 1,150 shares at $4.07 ($5K) on 2020-09-03, disclosed to the SEC on 2020-09-08.
Open-market purchase of $5k CRMD by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| Filing → |